T Jandlová - Concepedia

Author

T Jandlová

Czech Academy of Sciences, Institute of Molecular Genetics

Also Known As

E Kaczanowska, T Jandlova, T Jandlová, T. Jandlova, T. Jandlová

Publications

470

Citations

H-Index

Concepts

All Affiliations

Czech Academy of Sciences, Institute of Molecular Genetics Czech Academy of Sciences Wenner-Gren Foundations Institute of Haematology and Blood Transfusion Lundbeck Foundation

About

T Jandlová is an author at Czech Academy of Sciences, Institute of Molecular Genetics specializing in medicine, tumor microenvironment, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	328
2	Immunology	7	7	315
3	Cell Biology	3	3	154
4	Pathology	3	3	71
5	Health Sciences	1	1	62

T Jandlová

Publications

359

Citations

H-Index

Page 1

	Year	Citations
Immunotheraphy of cancer using local administration of lymphoid cells transformed by IL-2 cDNA and constitutively producing IL-2 J Bubeník, Jana Šímová, T Jandlová Immunology Letters Local AdministrationLymphoid NeoplasiaCancer ImmunosurveillanceIl-2 CdnaImmunology	1990	85
Local administration of cells containing an inserted IL-2 gene and producing IL-2 inhibits growth of human tumours in nu/nu mice J Bubeník, Nikolai N. Voitenok, J. Kieler, Immunology Letters Local AdministrationTumor BiologyCytokineImmunologyCell Proliferation	1988	80
Growth inhibition of a MC-induced mouse sarcoma by TCGF (IL 2)-containing preparations J Bubeník, Peter Perlmann, M Indrová, Cancer Immunology Immunotherapy Mc-induced Mouse SarcomaIl 2ImmunologyGrowth InhibitionCell Proliferation	1983	62
Interleukin 2 gene therapy of residual disease in mice carrying tumours induced by HPV 16. J Bubeník, Jana Šímová, R Hájková, International Journal of Oncology Murine Mc12 SarcomaIl-2 Gene TherapyImmunologyImmunoeditingPathology	1999	38
Defect in lectin-induced interleukin 2 production by peripheral blood lymphocytes of patients with invasive urinary bladder carcinoma J Bubeník, J. Kieler, V. Tromholt, Immunology Letters Urological ResearchUrologyLectin-induced Interleukin 2Peripheral Blood LymphocytesGenitourinary Cancer	1988	21
Prophylactic, therapeutic and anti-metastatic effects of BMDC and DC lines in mice carrying HPV 16-associated tumours Luis Mendoza, J Bubeník, Jana Šímová, International Journal of Oncology Dendritic CellImmunologyImmunoeditingDc LinesImmunotherapy	2003	17
Immunogenicity of Dendritic Cell-Based HPV16 E6/E7 Peptide Vaccines: CTL Activation and Protective Effects M Indrová, Milan Reiniš, J Bubeník, Folia Biologica	2004	16
Peritumoral Administration of Antigen-Unstimulated Bone Marrow-Derived Dendritic Cells Inhibits Tumour Growth Luis Mendoza, M Indrová, R Hájková, Folia Biologica	2000	15
Monoclonal antibodies against human urinary bladder carcinomas: Selectivity and utilization for gamma scintigraphy Jan Bubeník, J. Kieler, Peter Perlmann, European Journal of Cancer and Clinical Oncology Urological ResearchUrologyUrologic Cancer EpidemiologyGenitourinary CancerMedicine	1985	13
Tumour-inhibitory and antimetastatic effects of IL-2 in mice carrying MHC class I- tumours of HPV16 origin M Indrová, J Bubeník, Romana Mikyšková, International Journal of Oncology Hpv16 OriginIl-2 Gene TherapyMhc ClassImmunologyImmunoediting	2002	12

Page 1